T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GLOG
1376
DELISTED
GASLOG LTD
GLOG
| $8.63M | ﹤0.01% |
432,400
-355,810
| -45% | -$7.51M |
|
1377
Omnicell
OMCL
$1.72B
| $8.6M | ﹤0.01% |
227,920
+212,700
| +1,398% | +$7.76M |
|
1378
Ryder
R
$10.1B
| $8.44M | ﹤0.01% |
96,575
+2,500
| +3% | +$236K |
|
1379
Deckers Outdoor
DECK
$12.7B
| $8.42M | ﹤0.01% |
701,760
-82,800
| -11% | -$1.02M |
|
|
AFFX
1380
DELISTED
Affymetrix Inc
AFFX
| $8.4M | ﹤0.01% |
769,600
+198,700
| +35% | +$2.41M |
|
1381
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $8.4M | ﹤0.01% |
+212,000
| New | +$8.87M |
|
|
KITE
1382
DELISTED
Kite Pharma, Inc.
KITE
| $8.37M | ﹤0.01% |
+137,350
| New | +$7.84M |
|
|
HCBK
1383
DELISTED
HUDSON CITY BANCORP INC
HCBK
| $8.26M | ﹤0.01% |
835,589
| – | – |
|
|
MTCN
1384
DELISTED
ARCELORMITTAL 6% MANDATORILTY CONV SUB NT DUE 2016 (LUX)
MTCN
| $8.16M | ﹤0.01% |
522,826
+9,579
| +2% | +$162K |
|
1385
AutoNation
AN
$6.86B
| $8.14M | ﹤0.01% |
129,301
+1,300
| +1% | +$82.6K |
|
|
ABAX
1386
DELISTED
Abaxis Inc
ABAX
| $8.14M | ﹤0.01% |
158,100
+29,500
| +23% | +$1.66M |
|
|
MR
1387
DELISTED
Montage Resources Corporation Common Stock
MR
| $8.12M | ﹤0.01% |
102,855
+6
| +0% | +$555 |
|
|
PAY
1388
DELISTED
Verifone Systems Inc
PAY
| $8.02M | ﹤0.01% |
236,222
+14,020
| +6% | +$508K |
|
|
WFC.WS
1389
DELISTED
Wells Fargo & Company Ws
WFC.WS
| $7.99M | ﹤0.01% |
355,275
| – | – |
|
1390
iShares Russell 2000 Value ETF
IWN
$14.7B
| $7.99M | ﹤0.01% |
78,340
-27,120
| -26% | -$2.79M |
|
|
ANSS
1391
DELISTED
Ansys
ANSS
| $7.98M | ﹤0.01% |
87,484
+531
| +0.6% | +$47.2K |
|
|
NTUS
1392
DELISTED
Natus Medical Inc
NTUS
| $7.87M | ﹤0.01% |
+184,800
| New | +$7.36M |
|
|
STMP
1393
DELISTED
Stamps.com, Inc.
STMP
| $7.87M | ﹤0.01% |
+106,900
| New | +$7.34M |
|
|
AIG.WS
1394
DELISTED
American International Group, Inc.
AIG.WS
| $7.81M | ﹤0.01% |
281,700
| – | – |
|
|
HBMD
1395
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $7.78M | ﹤0.01% |
+580,260
| New | +$8M |
|
|
PGI
1396
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $7.72M | ﹤0.01% |
750,000
-94,984
| -11% | -$958K |
|
|
TE
1397
DELISTED
TECO ENERGY INC
TE
| $7.7M | ﹤0.01% |
436,085
+6,300
| +1% | +$118K |
|
1398
Commault Systems
CVLT
$6.22B
| $7.7M | ﹤0.01% |
181,500
-336,730
| -65% | -$15.3M |
|
1399
Stepan Co
SCL
$1.48B
| $7.62M | ﹤0.01% |
140,838
-4,800
| -3% | -$237K |
|
1400
Signet Jewelers
SIG
$3.56B
| $7.59M | ﹤0.01% |
59,200
+33,200
| +128% | +$4.45M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.